These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23652159)

  • 1. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-assisted treatment of opiate dependence is gaining favor.
    Jerry JM; Collins GB
    Cleve Clin J Med; 2013 Jun; 80(6):345-9. PubMed ID: 23733899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence.
    Levy-Gigi E; Kéri S; Shapiro AR; Sason A; Adelson M; Peles E
    Drug Alcohol Depend; 2014 Nov; 144():111-8. PubMed ID: 25220895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
    Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
    Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature.
    Taveros MC; Chuang EJ
    BMJ Support Palliat Care; 2017 Dec; 7(4):383-389. PubMed ID: 27566722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
    Ling W
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):394-400. PubMed ID: 27008037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.
    Voon P; Joe R; Fairgrieve C; Ahamad K
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27402654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.
    Van Hout MC; Crowley D; McBride A; Delargy I
    BMC Fam Pract; 2018 Jun; 19(1):103. PubMed ID: 29960593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ageing methadone population: A challenge for treating doctors.
    Nagarajan S; Wong A; Greene SL; Koutsogiannis Z
    Aust J Gen Pract; 2019 Mar; 48(3):111-112. PubMed ID: 31256476
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Categorising methadone: Addiction and analgesia.
    Keane H
    Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.